Replies to post #86892 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

LP did three television interviews in one day back in May 2013 explaining why DCVax-L could lower cancer therapy prices. Here is one.

DCVax-L should ultimately lower costs of U.S healthcare dramatically if it is approved. IMHO

Trump’s presidential transition website makes no mention of too-high drug prices, though it does say the new administration will “reform the Food and Drug Administration to put greater focus on the need of patients for new and innovative medical products.” -- Monarch

Put that together with Trump's statements today that he will lower drug care prices, and NWBO has an advantage since it can (may) enter a commercial environment where it shines as the poster child for a new and innovative economical cancer therapy.